U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C6H8O8.Ca.4H2O
Molecular Weight 320.262
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CALCIUM SACCHARATE

SMILES

O.O.O.O.[Ca++].O[C@@H]([C@H](O)[C@@H](O)C([O-])=O)[C@H](O)C([O-])=O

InChI

InChIKey=ZQWFSIZRQANUDA-WQMSYZFBSA-L
InChI=1S/C6H10O8.Ca.4H2O/c7-1(3(9)5(11)12)2(8)4(10)6(13)14;;;;;/h1-4,7-10H,(H,11,12)(H,13,14);;4*1H2/q;+2;;;;/p-2/t1-,2-,3-,4+;;;;;/m0...../s1

HIDE SMILES / InChI

Molecular Formula C6H10O8
Molecular Weight 210.1388
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula Ca
Molecular Weight 40.078
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Calcium-D-glucarate (also known as CALCIUM SACCHARATE) is the calcium salt of D-glucaric acid, a substance produced naturally in small amounts by mammals, including humans. Oral supplementation of calcium-D-glucarate has been shown to inhibit beta-glucuronidase, an enzyme produced by colonic microflora and involved in Phase II liver detoxification. Elevated beta-glucuronidase activity is associated with an increased risk for various cancers, particularly hormone-dependent cancers such as breast, prostate, and colon cancers. Other potential clinical applications of oral calcium-D-glucarate include regulation of estrogen metabolism and as a lipid-lowering. In addition, by reducing the beta-glucuronidase viability and activity of intestinal bacteria, salts of D-glucaric acid have been shown to enhance enterohepatic circulation and reduce steady state levels of cholesterol synthesis, resulting in decreased serum lipid levels.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Calcium-D-glucarate.
2002 Aug

Sample Use Guides

Take 1 to 3 caps 3 times daily with meals
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:19:09 GMT 2023
Edited
by admin
on Fri Dec 15 16:19:09 GMT 2023
Record UNII
6AP9J91K4V
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CALCIUM SACCHARATE
USP   USP-RS  
USP  
Official Name English
CALCIUM SACCHARATE [USP-RS]
Common Name English
CALCIUM D-GLUCARATE (1:1), TETRAHYDRATE
Common Name English
D-GLUCARIC ACID CALCIUM SALT TETRAHYDRATE
Common Name English
CALCIUM D-SACCHARATE TETRAHYDRATE
Common Name English
CALCIUM SACCHARATE [USP MONOGRAPH]
Common Name English
CALCIUM D-SACCHARATE, TETRAHYDRATE
Common Name English
Calcium saccharate tetrahydrate [WHO-DD]
Common Name English
CALCIUM SACCHARATE TETRAHYDRATE
WHO-DD  
Common Name English
D-GLUCARIC ACID, CALCIUM SALT (1:1 TETRAHYDRATE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1017
Created by admin on Fri Dec 15 16:19:09 GMT 2023 , Edited by admin on Fri Dec 15 16:19:09 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID70206633
Created by admin on Fri Dec 15 16:19:09 GMT 2023 , Edited by admin on Fri Dec 15 16:19:09 GMT 2023
PRIMARY
DAILYMED
6AP9J91K4V
Created by admin on Fri Dec 15 16:19:09 GMT 2023 , Edited by admin on Fri Dec 15 16:19:09 GMT 2023
PRIMARY
NCI_THESAURUS
C335
Created by admin on Fri Dec 15 16:19:09 GMT 2023 , Edited by admin on Fri Dec 15 16:19:09 GMT 2023
PRIMARY
CAS
5793-89-5
Created by admin on Fri Dec 15 16:19:09 GMT 2023 , Edited by admin on Fri Dec 15 16:19:09 GMT 2023
PRIMARY
DRUG BANK
DB13962
Created by admin on Fri Dec 15 16:19:09 GMT 2023 , Edited by admin on Fri Dec 15 16:19:09 GMT 2023
PRIMARY
RS_ITEM_NUM
1087202
Created by admin on Fri Dec 15 16:19:09 GMT 2023 , Edited by admin on Fri Dec 15 16:19:09 GMT 2023
PRIMARY
EVMPD
SUB178774
Created by admin on Fri Dec 15 16:19:09 GMT 2023 , Edited by admin on Fri Dec 15 16:19:09 GMT 2023
PRIMARY
RXCUI
236693
Created by admin on Fri Dec 15 16:19:09 GMT 2023 , Edited by admin on Fri Dec 15 16:19:09 GMT 2023
PRIMARY RxNorm
FDA UNII
6AP9J91K4V
Created by admin on Fri Dec 15 16:19:09 GMT 2023 , Edited by admin on Fri Dec 15 16:19:09 GMT 2023
PRIMARY
ChEMBL
CHEMBL2104217
Created by admin on Fri Dec 15 16:19:09 GMT 2023 , Edited by admin on Fri Dec 15 16:19:09 GMT 2023
PRIMARY
PUBCHEM
11954337
Created by admin on Fri Dec 15 16:19:09 GMT 2023 , Edited by admin on Fri Dec 15 16:19:09 GMT 2023
PRIMARY
SMS_ID
100000164383
Created by admin on Fri Dec 15 16:19:09 GMT 2023 , Edited by admin on Fri Dec 15 16:19:09 GMT 2023
PRIMARY
Related Record Type Details
ANHYDROUS->SOLVATE
PARENT -> SALT/SOLVATE